￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of whether Tarlatamab-Imdelltra is a targeted drug or an immune drug and its mechanism and clinical application

2026-02-01 22:25:32

Check Details
Analysis of telisotuzumab-EMRELIS medical insurance reimbursement ratio and policy differences in different regions

2026-02-01 22:25:32

Check Details
How to take tovorafenib tablets correctly and the dosage, taking time and precautions

2026-02-01 22:25:32

Check Details
Analysis of vorasidenib-VORANIGO reimbursement conditions and explanations of medical insurance policies and patient fees in different regions

2026-02-01 22:25:32

Check Details
How effective is Zongatinib (Zongatinib), its clinical trial results, patient experience and real feedback

2026-02-01 22:25:32

Check Details
Detailed description of the usage and dosage of vosoritide and the clinical medication regimen for patients of different ages and weights

2026-02-01 22:25:32

Check Details
Which diseases require the use of Methylcobalamin Injection (Rozebalamin) and classification of typical indications

2026-02-01 22:25:32

Check Details
Important indications for Trientine

2026-02-01 22:25:32

Check Details
Detailed interpretation of the instructions for use of mirikizumab

2026-02-01 22:25:32

Check Details
What are the possible consequences of long-term use of selumetinib/coceyu?

2026-02-01 22:25:32

Check Details
Lorlatinib/lorlatinib (Borina) belongs to the first generation of anti-cancer drugs

2026-02-01 22:25:32

Check Details
What drug class does Cabozantinib belong to?

2026-02-01 22:25:32

Check Details
Category
相关知识